247 results on '"Volchenko, N."'
Search Results
102. Influence of charge arrangement geometry and short-delay blasting on the crushing indices in compression blasting
- Author
-
Volchenko, N. G.
- Published
- 1977
- Full Text
- View/download PDF
103. Combined endoscopic treatment in the patient with inoperable middle third esophageal cancer (4-year clinical follow-up)
- Author
-
Filonenko, E. V., primary, Urlova, A. N., additional, and Volchenko, N. N., additional
- Published
- 2015
- Full Text
- View/download PDF
104. 809 Atomic force microscopy visualization of thyroid cancer
- Author
-
Reshetov, I., primary, Slavnova, E., additional, Volchenko, N., additional, and Shcherbina, V., additional
- Published
- 2015
- Full Text
- View/download PDF
105. Assessment of resection margins during organ-sparing surgery for breast cancer
- Author
-
Zikiryakhodjaev, A. D., primary, Volchenko, N. N., additional, Rasskazova, E. A., additional, Ermoshchenkova, M. V., additional, Sukhotko, A. S., additional, and Fetisova, E. Yu., additional
- Published
- 2015
- Full Text
- View/download PDF
106. Tubular adenoma of the breast
- Author
-
Fetisova, E. Yu., primary, Troshenkov, E. A., additional, Zikiryakhodzhaev, A. D., additional, Nikonov, I. V., additional, and Volchenko, N. N., additional
- Published
- 2015
- Full Text
- View/download PDF
107. Treatment for Paget’s disease: surgical approaches
- Author
-
Fetisova, E. Yu., primary, Zikiryakhodzhaev, A. D., additional, and Volchenko, N. N., additional
- Published
- 2015
- Full Text
- View/download PDF
108. Inflammatory myofibroblastic tumor of the breast
- Author
-
Saribekyan, E. K., primary, Zikiryakhodzhaev, A. D., additional, Volchenko, N. N., additional, Sukhotko, A. S., additional, and Petrov, A. N., additional
- Published
- 2015
- Full Text
- View/download PDF
109. Resection margin status during organ-sparing surgery for breast cancer
- Author
-
Zikiryakhodjaev, A. D., primary, Ermoshchenkova, M. V., additional, Volchenko, N. N., additional, Sukhotko, A. S., additional, Fetisova, E. Yu., additional, Rasskazova, E. A., additional, and Tyshchenko, E. V., additional
- Published
- 2015
- Full Text
- View/download PDF
110. Rapid intraoperative morphological diagnosis in oncology
- Author
-
Volchenko, N. N., primary, Borisova, O. V., additional, Ermolaeva, A. G., additional, Melnikova, V. Yu., additional, Petrov, A. N., additional, and Slavnova, E. N., additional
- Published
- 2015
- Full Text
- View/download PDF
111. Cytological diagnosis of malignant lymphomas and reactive changes in lymph nodes
- Author
-
Slavnova, E. N., primary and Volchenko, N. N., additional
- Published
- 2015
- Full Text
- View/download PDF
112. Simultaneous esophagectomy and lobectomy with bronchoplasty for synchronous esophageal and lung cancer
- Author
-
Ryabov, A. B., primary, Cheremisov, V. V., additional, Khomyakov, V. M., additional, Pikin, O. V., additional, Shemetova, M. M., additional, Telegina, L. V., additional, Volchenko, N. N., additional, Kolobaev, I. V., additional, Chaika, A. V., additional, and Kostrygin, A. K., additional
- Published
- 2015
- Full Text
- View/download PDF
113. 904 - Surgical management of papillary thyroid carcinoma according to BRAF mutation
- Author
-
Polyakov, A., Volchenko, N., Nikiforovich, P., Slavnova, E., Kudryavtseva, A., Ratushnyy, M., Motorin, O., Filushin, M., and Rebrikova, I.
- Published
- 2017
- Full Text
- View/download PDF
114. Working pits near buildings and plant at the antonovsk mining commission
- Author
-
Kobel'kov, G. P., Lebedkin, S. S., and Volchenko, N. G.
- Published
- 1979
- Full Text
- View/download PDF
115. Current endobronchial surgery in multiple primary lung cancer
- Author
-
Sokolov, V. V., primary, Telegina, L. V., additional, Pikin, O. V., additional, Volchenko, N. N., additional, and Rubtsova, N. A., additional
- Published
- 2014
- Full Text
- View/download PDF
116. 1076 The optimal extent of mediastinal lymphadenectomy in patients with non-small cell lung cancer
- Author
-
Traktenberg, A., primary, Frank, G., additional, Volchenko, N., additional, Kolbanov, K., additional, Stukalov, M., additional, and Pikin, O., additional
- Published
- 2003
- Full Text
- View/download PDF
117. 200 Efficacy of intraoperative cytological examination
- Author
-
Volchenko, N., primary, Gladunova, Z.D., additional, and Slavnova, E.N., additional
- Published
- 2003
- Full Text
- View/download PDF
118. CONTACT AND CONTACT-IMPACT INTERACTIONS IN MULTI-PAIR FRICTION ASSEMBLIES OF THE BAND-SHOE BRAKE.
- Author
-
KINDRACHUK, M. V., VOLCHENKO, N. A., VOLCHENKO, D. A., ZHURAVLEV, D. Y., and VOZNAJ, A. V.
- Subjects
CONTACT angle ,IMPACT (Mechanics) ,BRAKE systems ,FRICTION ,MECHANICAL behavior of materials ,METAL-metal bonds ,DETERIORATION of materials - Abstract
The theoretical and experimental application nature in multi-pair friction assemblies of the band-shoe brake of the combined brake bands is justified. The contact interaction in the pair «metal-metal» and the contact-impact interaction in the friction pair «pulley-straps» in multi-pair friction assemblies are considered. [ABSTRACT FROM AUTHOR]
- Published
- 2013
119. THE RATE OF HEATING OF METAL-POLYMER FRICTION PAIRS UNDER PULSE AND CONTINUOUS MODE OPERATION OF THE HEAT IN BAND-BLOCK BRAKE.
- Author
-
DZHANAHMEDOV, A. H., VOLCHENKO, A. I., VOLCHENKO, D. A., VOLCHENKO, N. A., and STEBELETSKAYA, N. M.
- Subjects
FRICTION materials ,HEATING ,METAL-filled plastics ,BRAKE systems ,SURFACES (Technology) ,TEMPERATURE effect - Abstract
We've illustrated the interconnection of the rate of heating of the metal and polymer friction elements in the band-block brakes with temperature gradients on their surfaces and depth of materials under pulsed and continuous mode operation of the heat. [ABSTRACT FROM AUTHOR]
- Published
- 2013
120. [Effect of water isotopic composition on Rhodococcus erythropolis biomass production]
- Author
-
Samkov, A. A., Stepan Dzhimak, Baryshev, M. G., Volchenko, N. N., Khudokormov, A. A., Samkova, S. M., and Karaseva, Év
121. [Confocal laser endomicroscopy principles and performing algorithm in gastric mucosa examination]
- Author
-
Pirogov, S. S., Sokolov, V. V., Karpova, E. S., Pavlov, P. V., Volchenko, N. N., and A.D Kaprin
122. [ENDOCYTOSCOPY--NOVEL ENDOSCOPIC DIAGNOSTICS APPROACH: PRINCIPLES AND PROCEDURE]
- Author
-
Sergey Pirogov, Sokolov, V. V., Kaprin, A. D., Volchenko, N. N., Karpova, E. S., Pavlov, P. V., Sukhin, D. G., Pogorelov, N. N., Ryabov, A. B., Khomyakov, V. M., and Chulikov, I. A.
123. [Early gastric cancer and precancerous conditions diagnostics with confocal laser endomicroscopy]
- Author
-
Sergey Pirogov, Sokolov, V. V., Karpova, E. S., Pavlov, P. V., Volchenko, N. N., and Kaprin, A. D.
124. [ENDOCYTOSCOPY--NEW TYPE OF ENDOSCOPIC EXAMINATION OF LOWER GASTROINTESTINAL AND RESPIRATORY TRACT]
- Author
-
Sergey Pirogov, Sokolov, V. V., Kaprin, A. D., Sokolov, D. V., Volchenko, N. N., Karpova, E. S., Pavlov, P. V., Telegina, L. V., Sukhin, D. G., Pogorelov, N. N., Ryabov, A. B., Khomyakov, V. M., and Chulikov, I. A.
125. Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study
- Author
-
Mohamad Mohty, Evangelos Terpos, Maria-Victoria Mateos, Michele Cavo, Sandra Lejniece, Meral Beksac, Mohamed Amine Bekadja, Wojciech Legiec, Meletios Dimopoulos, Svetlana Stankovic, Maria Soledad Durán, Valerio De Stefano, Alessandro Corso, Yulia Kochkareva, Edward Laane, Christian Berthou, Hans Salwender, Zvenyslava Masliak, Valdas Pečeliūnas, Wolfgang Willenbacher, João Silva, Vernon Louw, Damir Nemet, Zita Borbényi, Uri Abadi, Robert Schou Pedersen, Peter Černelč, Anna Potamianou, Catherine Couturier, Caroline Feys, Florence Thoret-Bauchet, Mario Boccadoro, Mohamed Bekadja, Rose-Marie Hamladji, Hocine Ait Ali, Selma Hamdi, Hadj Touhami, Nourredine Sidi Mansour, Werner Linkesch, Robert Shou Pedersen, Niels Abildgaard, Marju Hein, Jean Richard Eveillard, Abderrazak el Yamani, Philippe Moreau, Laurence Sanhes, Gérard Lepeu, Kamel Laribi, Eric Jourdan, Olivier Fitoussi, Olivier Allangba, Joël Fleury, Martine Escoffre, Riad Benramdane, Guillaume Cartron, Gérard Dine, Eric Legouffe, Hanns-Detlev Harich, Thomas Illmer, Steffen Dörfel, Carla Verena Hannig, Michael Koenigsmann, Gabriele Prange-Krex, Ingo Tamm, Wolfgang Zeller, Michael Maasberg, Rudolf Schlag, Martine Klausmann, Jens Uhlig, Burkhard Alkemper, Stefan Schütz, Hans-Werner Tessen, Benno Mohr, Peter Schmidt, Bernhard Heinrich, Holger Hebart, Gernot Seipelt, Thomas Zoeller, Frank Heits, Clemens Müller-Naendrup, Richard Hansen, Roland Repp, Ludwig Fischer Von Weikersthal, Rudolf Schmits, Jörg Heßling, B. Krammer-Steiner, Viktor Janzen, Michael Schauer, Marcus W. Grüner, Jens Kisro, Claudio Denzlinger, Werner Freier, Christian Junghanss, Martin Görner, Katharina Laichinger, Helmut Ostermann, Heinz Dürk, Georg Hess, Gernot Reich, Panagiota Matsouka, Anastasia Pouli, Achilles Anagnostopoulos, Tamas Masszi, Janos Ivanyi, Arpad Szomor, Arnon Nagler, Hila Magen, Irit Avivi, Miriam Quitt, Antonio Palumbo, Tommaso Za, Daniele Vallisa, Roberto Foa, Alberto Bosi, Angelo Vacca, Francesco Lanza, Giulia Palazzo, Giuseppe Avvisati, Felicetto Ferrara, Ugo Consoli, Maria Cantonetti, Emanuele Angelucci, Catello Califano, Francesco Di Raimondo, Attilio Guarini, Maurizio Musso, Michele Pizzuti, Nicola Giuliani, Antonio Ardizzoia, Nicola Di Renzo, Gianluca Gaidano, Alessandro Gozzetti, Vincenzo Pitini, Gabriella Farina, Riccardo Centurioni, Paolo De Fabritiis, Francesco Iuliano, Giorgio La Nasa, Giacinto La Verde, Fabrizio Pane, Umberto Recine, Maria La Targia, Giuseppe Mineo, Clotilde Cangialosi, Daniele Fagnani, Augusto Federici, Atelda Romano, Giorgina Specchia, Sergio Storti, Velia Bongarzoni, Andrea Bacigalupo, Marco Gobbi, Giancarlo Latte, Donato Mannina, Silvana Capalbo, Mindaugas Jurgutis, Dariusz Woszczyk, Jadwiga Hołojda, Slawomir Gornik, Andrzej Pluta, Elzbieta Morawiec-Szymonik, Slawomira Kyrcz-Krzemien, Wojciech Homenda, Sebastian Grosicki, Kazimierz Sulek, Andrzej Lange, Janusz Kloczko, Jolanta Starzak-Gwozdz, Andrzej Hellmann, Mieczyslaw Komarnicki, Kazimierz Kuliczkowski, Carolina Viveiros, Cristina Gonçalves, Natalia Esefyeva, Julia Kochkareva, Kamil Kaplanov, Elena Volodicheva, Elena Laricheva, Valentina Dergacheva, Marina Chukavina, Natalia Volchenko, Irina Nazarova, Ludmila Anchukova, Elena Ovanesova, Taras Gritsenko, Galina Salogub, Ludmila Magomedova, Irina Kuznetsova, Svetlana Osyunikhina, Olga Serdyuk, Elena Karyagina, Valentina Ivanova, Slovenia Peter Černelč, Corlia Coetzee, Karen Gunther, Dhayanithi Moodley, Soledad Duran, Asunción Echeveste Gutiérrez, Jaime Perez De Oteyza, Francisco Javier Capote, Maria Casanova, Jesus Martin Sanchez, Eduardo Rios-Herranz, Jeronima Ibañez-Garcia, Maria Jose Herranz, Belen Hernandez, Sara Sanchez Sanchez, Fernando Escalante, Fernando Carnicero, Joan Bargay Lleonart, Mercedes Gironella, Rafael Martínez, Ana Lopez De La Guia, Luis Palomera, Rebeca Iglesias, Fernando Solano Ramos, Javier De La Serna, Pedro Garcia Sanchez, Juan Besalduch Vidal, Miguel Diaz Morfa, Turkey – Meral Beksac, Filiz Vural, Yildiz Aydin, Ali Unal, Hakan Goker, Oktay Bilgir, Birol Guvenc, Mehmet Turgut, Gulsum Gulistan Ozet, Ridvan Ali, Maryna Kyselyova, Nataliia Glushko, Renata Vybyrana, Igor Skrypnyk, Natalya Tretyak, Tetiana Kharchevska, Iryna Dyagil, Tetiana Popovs'ka, Vadim Shimanskiy, Tamila Lysa, Hanna Oliynyk, Kateryna Vilchevskaya, Iryna Kryachok, Yuriy Popovych, Natalia Romanyuk, Natalia Yushchenko, Polina Kaplan, Grygoriy Rekhtman, Halyna Pylypenko, Viktor Kozlov, Johannes Drach, Jean-Luc Harousseau, Hermann Einsele, Hartmut Goldschmidt, Thierry Facon, Mauricette Michalet, Valery G. Savchenko, Javier De la Rubia, Gordon Cook, Ulf-Henrik Mellqvist, Heinz Ludwig, Millennium Pharmaceuticals, Janssen Research and Development, Mohty, Mohamad, Terpos, Evangelo, Mateos, Maria-Victoria, Cavo, Michele, Lejniece, Sandra, Beksac, Meral, Bekadja, Mohamed Amine, Legiec, Wojciech, Dimopoulos, Meletio, Stankovic, Svetlana, Durán, Maria Soledad, De Stefano, Valerio, Corso, Alessandro, Kochkareva, Yulia, Laane, Edward, Berthou, Christian, Salwender, Han, Masliak, Zvenyslava, Pečeliūnas, Valda, Willenbacher, Wolfgang, Silva, João, Louw, Vernon, Nemet, Damir, Borbényi, Zita, Abadi, Uri, Pedersen, Robert Schou, Černelč, Peter, Potamianou, Anna, Couturier, Catherine, Feys, Caroline, Thoret-Bauchet, Florence, Boccadoro, Mario, Mohty, M., Terpos, E., Mateos, M. -V., Cavo, M., Lejniece, S., Beksac, M., Bekadja, M. A., Legiec, W., Dimopoulos, M., Stankovic, S., Duran, M. S., De Stefano, V., Corso, A., Kochkareva, Y., Laane, E., Berthou, C., Salwender, H., Masliak, Z., Peceliunas, V., Willenbacher, W., Silva, J., Louw, V., Nemet, D., Borbenyi, Z., Abadi, U., Pedersen, R. S., Cernelc, P., Potamianou, A., Couturier, C., Feys, C., Thoret-Bauchet, F., Boccadoro, M., Bekadja, M., Hamladji, R. -M., Ali, H. A., Hamdi, S., Touhami, H., Mansour, N. S., Linkesch, W., Abildgaard, N., Hein, M., Eveillard, J. R., Yamani, A. E., Moreau, P., Sanhes, L., Lepeu, G., Laribi, K., Jourdan, E., Fitoussi, O., Allangba, O., Fleury, J., Escoffre, M., Benramdane, R., Cartron, G., Dine, G., Legouffe, E., Harich, H. -D., Illmer, T., Dorfel, S., Hannig, C. V., Koenigsmann, M., Prange-Krex, G., Tamm, I., Zeller, W., Maasberg, M., Schlag, R., Klausmann, M., Uhlig, J., Alkemper, B., Schutz, S., Tessen, H. -W., Mohr, B., Schmidt, P., Heinrich, B., Hebart, H., Seipelt, G., Zoeller, T., Heits, F., Muller-Naendrup, C., Hansen, R., Repp, R., Von Weikersthal, L. F., Schmits, R., Hessling, J., Krammer-Steiner, B., Janzen, V., Schauer, M., Gruner, M. W., Kisro, J., Denzlinger, C., Freier, W., Junghanss, C., Gorner, M., Laichinger, K., Ostermann, H., Durk, H., Hess, G., Reich, G., Matsouka, P., Pouli, A., Anagnostopoulos, A., Masszi, T., Ivanyi, J., Szomor, A., Nagler, A., Magen, H., Avivi, I., Quitt, M., Palumbo, A., Za, T., Vallisa, D., Foa, R., Bosi, A., Vacca, A., Lanza, F., Palazzo, G., Avvisati, G., Ferrara, F., Consoli, U., Cantonetti, M., Angelucci, E., Califano, C., Di Raimondo, F., Guarini, A., Musso, M., Pizzuti, M., Giuliani, N., Ardizzoia, A., Di Renzo, N., Gaidano, G., Gozzetti, A., Pitini, V., Farina, G., Centurioni, R., De Fabritiis, P., Iuliano, F., La Nasa, G., La Verde, G., Pane, F., Recine, U., La Targia, M., Mineo, G., Cangialosi, C., Fagnani, D., Federici, A., Romano, A., Specchia, G., Storti, S., Bongarzoni, V., Bacigalupo, A., Gobbi, M., Latte, G., Mannina, D., Capalbo, S., Jurgutis, M., Woszczyk, D., Holojda, J., Gornik, S., Pluta, A., Morawiec-Szymonik, E., Kyrcz-Krzemien, S., Homenda, W., Grosicki, S., Sulek, K., Lange, A., Kloczko, J., Starzak-Gwozdz, J., Hellmann, A., Komarnicki, M., Kuliczkowski, K., Viveiros, C., Goncalves, C., Esefyeva, N., Kaplanov, K., Volodicheva, E., Laricheva, E., Dergacheva, V., Chukavina, M., Volchenko, N., Nazarova, I., Anchukova, L., Ovanesova, E., Salogub, G., Magomedova, L., Kuznetsova, I., Osyunikhina, S., Serdyuk, O., Karyagina, E., Ivanova, V., Cernelc, S. P., Coetzee, C., Gunther, K., Moodley, D., Duran, S., Gutierrez, A. E., De Oteyza, J. P., Capote, F. J., Casanova, M., Sanchez, J. M., Rios-Herranz, E., Ibanez-Garcia, J., Herranz, M. J., Hernandez, B., Sanchez, S. S., Escalante, F., Carnicero, F., Lleonart, J. B., Gironella, M., Martinez, R., De La Guia, A. L., Palomera, L., Iglesias, R., Ramos, F. S., De La Serna, J., Sanchez, P. G., Vidal, J. B., Morfa, M. D., Beksac, T. -M., Vural, F., Aydin, Y., Unal, A., Goker, H., Bilgir, O., Guvenc, B., Turgut, M., Ozet, G. G., Ali, R., Kyselyova, M., Glushko, N., Vybyrana, R., Skrypnyk, I., Tretyak, N., Kharchevska, T., Dyagil, I., Popovs'Ka, T., Shimanskiy, V., Lysa, T., Oliynyk, H., Vilchevskaya, K., Kryachok, I., Popovych, Y., Romanyuk, N., Yushchenko, N., Kaplan, P., Rekhtman, G., Pylypenko, H., Kozlov, V., Drach, J., Harousseau, J. -L., Einsele, H., Goldschmidt, H., Facon, T., Michalet, M., Savchenko, V. G., De la Rubia, J., Cook, G., Mellqvist, U. -H., Ludwig, H., Service d'hématologie clinique et de thérapie cellulaire [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Department of Clinical Therapeutics, Univesrity of Athens, Universidad de Salamanca- CSIC, The Institute of Hematology and Oncology L. and A. Seràgnoli, Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO), Riga Stradins University (RSU), Ankara University, University of Oran Es-Senia [Oran] | Université d'Oran Es-Senia [Oran], Medical University of Lublin, Department of Clinical Therapeutics [Athens, Greece], National and Kapodistrian University of Athens (NKUA), University Clinic of Hematology, Skopje, Complejo Hospitalario de Jaén, Institute of Hematology, Catholic University, Division of Hematology, Foundation IRCCS Policlinico San Matteo, Università degli Studi di Pavia, State Budget Healthcare Insititution of Moscow, North Estonia Medical Centre, Service d'hématologie, Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Lymphocyte B et Auto-immunité (LBAI), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO), Asklepios Klinik Altona, Institute of Blood Pathology and Transfusion Medicine, Lviv, Vilnius University Hospital Santariskiu Clinics, Universitätsklinik Innsbruck Innere Medizin V (Innsbruck Austria & Oncotyrol), Instituto de Engenharia de Sistemas e Computadores Investigação e Desenvolvimento em Lisboa (INESC-ID), Instituto Superior Técnico, Universidade Técnica de Lisboa (IST)-Instituto de Engenharia de Sistemas e Computadores (INESC), University Health Network, University of the Free State [South Africa], Clinical Hospital Centre Zagreb, Szegedi Tudományegyetem, Meir Medical Center, Regionshospitalet i Holstebro, Medicinsk Afdeling, University Medical Centre Ljubljana [Ljubljana, Slovenia] (UMCL), Janssen-Cilag, Neuss, Janssen-Cilag [Issy-les-Moulineaux], Janssen Research & Development, Divisione di Ematologia dell' Università di Torino, and Azienda Ospedaliera S. Giovanni Battista di Torino
- Subjects
Male ,Cancer Research ,Boronic Acid ,[SDV]Life Sciences [q-bio] ,bortezomib ,global ,observational study ,routine practice ,stem cell transplantation ,Salvage therapy ,Practice Patterns ,Dexamethasone ,Bortezomib ,Routine practice ,0302 clinical medicine ,Global ,Observational study ,Stem cell transplantation ,hemic and lymphatic diseases ,Antineoplastic Combined Chemotherapy Protocols ,80 and over ,Prospective Studies ,Practice Patterns, Physicians' ,Prospective cohort study ,Lenalidomide ,ComputingMilieux_MISCELLANEOUS ,Multiple myeloma ,Aged, 80 and over ,Hematology ,Middle Aged ,Boronic Acids ,3. Good health ,Thalidomide ,Survival Rate ,Treatment Outcome ,Local ,Oncology ,030220 oncology & carcinogenesis ,Female ,Multiple Myeloma ,Adult ,Aged ,Follow-Up Studies ,Humans ,Neoplasm Recurrence, Local ,Salvage Therapy ,medicine.drug ,Human ,medicine.medical_specialty ,NO ,Follow-Up Studie ,03 medical and health sciences ,Internal medicine ,medicine ,Survival rate ,Physicians' ,Antineoplastic Combined Chemotherapy Protocol ,business.industry ,Settore MED/15 ,medicine.disease ,Transplantation ,Settore MED/15 - MALATTIE DEL SANGUE ,Prospective Studie ,Neoplasm Recurrence ,business ,030215 immunology - Abstract
© 2018 The Authors., [Background]: The present prospective, multinational, noninterventional study aimed to document and describe real-world treatment regimens and disease progression in multiple myeloma (MM) patients. [Patients and Methods]: Adult patients initiating any new MM therapy from October 2010 to October 2012 were eligible. A multistage patient/site recruitment model was applied to minimize the selection bias; enrollment was stratified by country, region, and practice type. The patient medical and disease features, treatment history, and remission status were recorded at baseline, and prospective data on treatment, efficacy, and safety were collected electronically every 3 months., [Results]: A total of 2358 patients were enrolled. Of these patients, 775 and 1583 did and did not undergo stem cell transplantation (SCT) at any time during treatment, respectively. Of the patients in the SCT and non-SCT groups, 49%, 21%, 14%, and 15% and 57%, 20%, 12% and 10% were enrolled at treatment line 1, 2, 3, and ≥ 4, respectively. In the SCT and non-SCT groups, 45% and 54% of the patients had received bortezomib-based therapy without thalidomide/lenalidomide, 12% and 18% had received thalidomide/lenalidomide-based therapy without bortezomib, and 30% and 4% had received bortezomib plus thalidomide/lenalidomide-based therapy as frontline treatment, respectively. The corresponding proportions of SCT and non-SCT patients in lines 2, 3, and ≥ 4 were 45% and 37%, 30% and 37%, and 12% and 3%, 33% and 27%, 35% and 32%, and 8% and 2%, and 27% and 27%, 27% and 23%, and 6% and 4%, respectively. In the SCT and non-SCT patients, the overall response rate was 86% to 97% and 64% to 85% in line 1, 74% to 78% and 59% to 68% in line 2, 55% to 83% and 48% to 60% in line 3, and 49% to 65% and 36% and 45% in line 4, respectively, for regimens that included bortezomib and/or thalidomide/lenalidomide., [Conclusion]: The results of our prospective study have revealed great diversity in the treatment regimens used to manage MM in real-life practice. This diversity was linked to factors such as novel agent accessibility and evolving treatment recommendations. Our results provide insight into associated clinical benefits., Writing support during the development of our report was provided by Laura Mulcahy and Catherine Crookes of FireKite, an Ashfield company, a part of UDG Healthcare plc, which was funded by Millennium Pharmaceuticals, Inc, and Janssen Global Services, LLC. The EMMOS study was supported by research funding from Janssen Pharmaceutical NV and Millennium Pharmaceuticals, Inc.
- Published
- 2018
- Full Text
- View/download PDF
126. [Laryngeal carcinosarcoma].
- Author
-
Kozhanov AL, Kozhanov LG, Volchenko NN, Chernotalova NS, and Uglova AK
- Subjects
- Humans, Diagnosis, Differential, Laryngectomy methods, Laryngoscopy methods, Larynx pathology, Carcinosarcoma diagnosis, Carcinosarcoma pathology, Laryngeal Neoplasms diagnosis, Laryngeal Neoplasms pathology
- Abstract
A clinical case of a rare malignant tumor of the larynx, carcinosarcoma, is described. The features of the clinical picture, diagnostic methods: instrumental and morphological are presented.
- Published
- 2024
- Full Text
- View/download PDF
127. Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report.
- Author
-
Kornietskaya A, Evdokimova S, Kachmazov A, Fedenko A, Bolotina L, Sidorov D, Volchenko N, Goeva N, Govaleshko A, and Kaprin A
- Abstract
Solid pseudopapillary neoplasm (SPN) of the pancreas is an extremely rare tumor, associated with favorable prognosis and long-term survival in patients with advanced disease. However, limited data exist on systemic therapy for such patients. Herein, we present a case of a young woman with a history of SPN, who progressed after multiple surgical resections and chemotherapy regimens. The immunohistochemistry (IHC) showed overexpression of estrogen receptors (ER) and progesterone receptors (PR) in tumor tissue. The patient started to receive tamoxifen and showed a durable response to endocrine therapy., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Kornietskaya, Evdokimova, Kachmazov, Fedenko, Bolotina, Sidorov, Volchenko, Goeva, Govaleshko and Kaprin.)
- Published
- 2022
- Full Text
- View/download PDF
128. Case Report: Genetic Alterations Associated with the Progression of Carotid Paraganglioma.
- Author
-
Pavlov V, Snezhkina A, Kalinin D, Golovyuk A, Kobelyatskaya A, Bakhtogarimov I, Volchenko N, Krasnov G, and Kudryavtseva A
- Subjects
- Adult, Biomarkers, Tumor, DNA Mutational Analysis, Disease Progression, Female, Genetic Testing, Humans, Immunohistochemistry, Mutation, Paraganglioma therapy, Succinate Dehydrogenase genetics, Succinate Dehydrogenase metabolism, Carotid Body pathology, Genetic Association Studies, Genetic Predisposition to Disease, Genetic Variation, Paraganglioma diagnosis, Paraganglioma genetics
- Abstract
Paragangliomas (PGLs) are rare neuroendocrine tumors that can develop from any paraganglion across the body. The carotid body is the most often location of PGLs in the head and neck region. Carotid PGLs (CPGLs) are characterized by predominantly non-aggressive behavior; however, all tumors have the potential to metastasize. To date, molecular mechanisms of paraganglioma progression remain elusive. We report a case of a 38-year-old woman with metastatic CPGL manifesting as a recurrent tumor with lymph node metastasis. The tumor was fast-growing and had a high Ki-67 proliferation index. Immunohistochemical (IHC) examination and whole-exome sequencing were performed for both recurrent tumor and metastasis. A germline pathogenic splice acceptor variant in the SDHB gene was found in the patient. Immunoreactivity of the SDHB subunit was weak diffuse in both samples, indicating deficiency of the succinate dehydrogenase. Moreover, the recurrent tumor exhibited loss of heterozygosity (LOH) at the SDHB locus, that is according to Knudson's "two-hit" hypothesis of cancer causation. We also identified a rare somatic promotor mutation in the TERT gene associated with the tumor progression. Obtained results confirmed the indicative role of the germline SDHB mutation for metastatic CPGLs, as well as the potential prognostic value of the TERT promoter mutation.
- Published
- 2021
- Full Text
- View/download PDF
129. [Endolaryngeal resection of the larynx for adenocystic cancer].
- Author
-
Kozhanov AL, Kozhanov LG, Kravtsov SA, Volchenko NN, and Vyaltseva YY
- Subjects
- Humans, Middle Aged, Pharynx, Carcinoma, Adenoid Cystic, Laryngeal Neoplasms diagnosis, Laryngeal Neoplasms surgery, Larynx surgery
- Abstract
Adenocystic carcinoma accounts for 3-5% of all malignant neoplasms of the head and neck organs. Due to the rarity of detecting this cancer in the larynx, treatment options are still controversial: surgery with postoperative radiation therapy or surgery alone. Patient A. , 64 years old, turned to the City Clinical Oncological Hospital No. 1 in October 2019 with complaints of moderate pain when swallowing, sensation of a foreign body. Fibrolaryngoscopy revealed an exophytic form of growth bright red color formation with a small tuberous surface up to 12 mm in size in the area of the free left edge of the epiglottis. There was a thickening of the pharyngeal-epiglottis fold. Histological examination revealed adenocystic cancer. Diagnosed with Laryngeal cancer with cT1N0M0. On December 23, 2019, endolaryngeal resection of the larynx was performed using an operating microscope in the volume R0. This observation is of interest both in morphological terms (extremely rarely detected cancer of the larynx) and in terms of treatment (an organ-preserving operation was performed - endolaryngeal resection of the larynx).
- Published
- 2021
- Full Text
- View/download PDF
130. [Metastatic solid pseudopapillary tumor in the perinephric fat without a primary identified focus].
- Author
-
Surkova VS, Volchenko NN, Vorobyev NV, Gevorgyan GS, Yudakova ME, and Tkachuk AV
- Subjects
- Female, Humans, Pancreas, Pancreatic Neoplasms
- Abstract
Solid pseudopapillary tumor of the pancreas is an extremely rare neoplasm of the exocrine portion of this organ, which affects mostly young women and is characterized by a low malignancy potential and a relatively benign clinical course. According to the literature, even in disease progression as metastases, the overall 5-year survival rate is more than 95%. The paper describes a clinical case of a female patient with a solid pseudopapillary pancreatic tumor regarded as a metastatic neoplasm in the retroperitoneal space after surgical treatment previously performed in 2001.
- Published
- 2021
- Full Text
- View/download PDF
131. CEACAM5 overexpression is a reliable characteristic of CD133-positive colorectal cancer stem cells.
- Author
-
Gisina A, Novikova S, Kim Y, Sidorov D, Bykasov S, Volchenko N, Kaprin A, Zgoda V, Yarygin K, and Lupatov A
- Subjects
- GPI-Linked Proteins metabolism, Humans, AC133 Antigen metabolism, Carcinoembryonic Antigen metabolism, Colonic Neoplasms genetics, Neoplastic Stem Cells metabolism
- Abstract
Background: CD133 (prominin-1) is the most commonly used molecular marker of the cancer stem cells (CSCs) that maintain tumor progression and recurrence in colorectal cancer. However, the proteome of CSCs directly isolated from colorectal tumors based on CD133 expression has never been investigated., Objective: To reveal biomarkers of CD133-positive colorectal CSCs., Methods: Thirty colorectal tumor samples were collected from patients undergoing bowel resection. CD133-positive and CD133-negative cells were isolated by FACS. Comparative proteomic profiling was performed by LC-MS/MS analysis combined with label-free quantification. Verification of differentially expressed proteins was performed by flow cytometry or ELISA. CD133-knockout Caco-2 and HT-29 cell lines were generated using CRISPR-Cas9 gene editing., Results: LC-MS/MS analysis identified 29 proteins with at least 2.5-fold higher expression in CD133-positive cells versus CD133-negative cells. Flow cytometry confirmed CEACAM5 overexpression in CD133-positive cells in all clinical samples analyzed. S100A8, S100A9, and DEFA1 were differentially expressed in only a proportion of the samples. CD133 knockout in the colon cancer cell lines Caco-2 and HT-29 did not affect the median level of CEACAM5 expression, but led to higher variance of the percentage of CEACAM5-positive cells., Conclusions: High CEACAM5 expression in colorectal cancer cells is firmly associated with the CD133-positive colorectal CSC phenotype, but it is unlikely that CD133 directly regulates CEACAM5 expression.
- Published
- 2021
- Full Text
- View/download PDF
132. [Expression of ganglioside GD2 on colorectal adenocarcinoma cells].
- Author
-
Lupatov AY, Gisina AM, Kim YS, Bykasov SA, Volchenko NN, Sidorov DV, Yarygin KN, and Kholodenko RV
- Subjects
- Caco-2 Cells, HT29 Cells, Humans, Adenocarcinoma metabolism, Colorectal Neoplasms metabolism, Gangliosides metabolism
- Abstract
Using flow cytometry GD2 ganglioside expression was evaluated both on colorectal adenocarcinoma cell lines and on tumor tissue samples from colorectal cancer patients. The marker was found on EpCAM-positive tumor cells in 6 of 12 patients' samples but not on the HT29 and CaCo-2 cell lines. GD2 expression was not an exceptional feature of cancer stem cells, since its expression level was similar on CD133-positive and CD133-negative tumor cells. Thus, the presence of GD2 ganglioside was revealed on colorectal adenocarcinoma cells for the first time. This finding makes it possible to use targeted therapy to treat this disease.
- Published
- 2020
- Full Text
- View/download PDF
133. [Solitary fibrous tumor of pleura (symptoms, diagnosis, treatment)].
- Author
-
Salimov ZM, Pikin OV, Ryabov AB, Popov MI, Kononets PV, Volchenko NN, Blinov DA, and Nikulin KA
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Immunohistochemistry, Male, Middle Aged, Neoplasm Recurrence, Local surgery, Pleura, Solitary Fibrous Tumor, Pleural metabolism, Solitary Fibrous Tumor, Pleural mortality, Survival Analysis, Thoracic Surgical Procedures, Neoplasm Recurrence, Local pathology, STAT6 Transcription Factor biosynthesis, Solitary Fibrous Tumor, Pleural diagnosis, Solitary Fibrous Tumor, Pleural surgery
- Abstract
Objective: Optimization of diagnosis and treatment of patients with solitary fibrous tumor of pleura, analysis of overall survival and disease-free survival, predictors of recurrence., Material and Methods: There were 66 patients with solitary fibrous tumor of pleura (26 men and 40 women) aged 57.6 years (range 26-80 years). Asymptomatic course was found in 29 (44%) patients, various symptoms - in 37 (56%) patients. Thoracotomy was applied in 36 patients, thoracoscopy - in 30 patients. Immunohistochemical examination included analysis of definition of Stat6 expression., Results: Benign variant of SFT was diagnosed in 50 (75.7%) patients, malignant variant - in 16 (24.3%) patients. STAT6 expression was observed in all cases. Postoperative morbidity was 9%, mortality - 1.6%. Recurrence was diagnosed in 2 (4%) patients with benign variant of disease and in 5 (31.2%) patients with malignant variant (2 of them died from progression of disease). Progression-free survival was 89.4%, overall survival - 95.4%. Predictors of recurrence are tumor dimension over 10 cm, necrosis and/or hemorrhagic component of tumor, mitotic count of at least four per 10 high-power fields., Conclusion. S: Olitary fibrous tumor of pleura is a rare mesenchymal fibroblastic neoplasm growing from submesothelial layer. Differential and preoperative morphological diagnosis of SFT is difficult and demands a special immunohistochemical examination with analysis of Stat 6 expression. Surgery is preferred for tumor de novo and recurrent neoplasm.
- Published
- 2020
- Full Text
- View/download PDF
134. Primary chondrosarcoma of the trachea with extensive extraluminal growth.
- Author
-
Ryabov A, Pikin O, Sokolov V, and Volchenko N
- Subjects
- Biopsy, Needle, Chondrosarcoma complications, Chondrosarcoma diagnosis, Humans, Male, Middle Aged, Tomography, X-Ray Computed, Trachea diagnostic imaging, Tracheal Neoplasms complications, Tracheal Neoplasms diagnosis, Tracheal Stenosis diagnosis, Tracheal Stenosis etiology, Chondrosarcoma surgery, Endoscopy methods, Neoplasm Staging, Pulmonary Surgical Procedures methods, Trachea surgery, Tracheal Neoplasms surgery, Tracheal Stenosis surgery
- Abstract
Primary chondrosarcoma of the trachea is an extremely rare non-epithelial neoplasm with only few cases published in the literature. We present a rare case of tracheal chondrosarcoma with extensive extraluminal growth. We operated a patient with obstructive tumour of the upper third of the trachea via partial sternotomy. Before surgery, a Hanarostent was put into the trachea to treat a life-threatening stenosis. Postoperative period was uneventful. We discuss the incidence, clinical presentation and treatment options in patients with rare tracheal tumours. In some cases, a multidisciplinary approach (endoscopic intervention followed by surgical resection) is an effective treatment tool., (© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
135. [The difficulties of cytologic diagnostic of breast diseases based on trepanobiopsy samples.]
- Author
-
Volchenko NN, Borisova OV, Ermolaeva AG, Melnikova VY, and Petrov AN
- Abstract
The article analyses, on the basis of scientific publications and original data, the causes of erroneous cytological conclusion concerning samples of trepanobiopsies of mammary gland. The most prevalent benign affections that are characterized by most frequent hyper diagnostic of cancer are fibro-adenoma with proliferation of epithelium and sclerosing adenosis. At the same time, certain modifications of lobular carcinoma of mammary gland, tubular, papillary cancer as well as highly differentiated invasive carcinoma of nonspecific type from cells with ulterior nuclear atypism sometimes it is difficult to diagnose at the cellular level. The sensitivity of cytological diagnostic of pathology of mammary gland using samples of trepanobiopsies makes up 97.5%, specificity - 98.5%. The number of false positive cytological conclusions about presence of malignant tumor makes up to 0.6%, false negative - 1.5%. The reliability of cytological analysis makes up to 97.4%, efficiency - 96.3%., Competing Interests: The authors declare no conflict of interest.
- Published
- 2017
- Full Text
- View/download PDF
136. [The application of automated system of evaluation of morphology of cells for diagnostic of Hodgkin's lymphoma in education process of course of clinical oncocytology].
- Author
-
Slavnova EN and Volchenko NN
- Subjects
- Child, Diagnosis, Differential, Female, Hodgkin Disease diagnostic imaging, Hodgkin Disease pathology, Humans, Lymphoma, B-Cell diagnostic imaging, Lymphoma, B-Cell pathology, Male, Middle Aged, Cytodiagnosis methods, Education, Medical, Hodgkin Disease diagnosis, Lymphoma, B-Cell diagnosis
- Abstract
The analysis of cytological analysis data demonstrated that cytological diagnosis of Hodgkin's lymphoma was established properly in exact and estimated form in 92.8%. The cytological reports mentioned no alternatives. The cytological analysis system Vision Cyto® was applied to analyze cellular content by micro photos of cytological samples of 119 patients with established morphologic (histological and cytological) diagnosis of Hodgkin's lymphoma. On the basis of the received data training programs were developed concerning cytological diagnostic and detection of forms of disease. The gallery was organized concerning pictures of tumor and background cells playing key role in cytological diagnostic. The distinctive differential diagnostic indications of various forms of Hodgkin's lymphoma were established.
- Published
- 2016
137. Bidirectional chemotherapy in gastric cancer with peritoneal metastasis combining intravenous XELOX with intraperitoneal chemotherapy with low-dose cisplatin and Doxorubicin administered as a pressurized aerosol: an open-label, Phase-2 study (PIPAC-GA2).
- Author
-
Khomyakov V, Ryabov A, Ivanov A, Bolotina L, Utkina A, Volchenko N, and Kaprin A
- Abstract
Background : Peritoneal metastasis (PM) develop in more than 50 % of gastric cancer (GC) patients. Median survival without treatment is not more than 3-7 months, and 8-12 months after modern combination chemotherapy. Innovative therapeutic approaches are urgently needed. Methods : Phase-2, open label prospective clinical trial assessing safety and efficacy of bidirectional chemotherapy for treating peritoneal metastasis of gastric cancer (PMGC). Treatment protocol included initial staging laparoscopy or laparotomy, 3-4 courses of systemic chemotherapy (XELOX) followed by Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC) procedures every 6 weeks until progression of disease or death. Primary endpoints were overall survival and histological peritoneal regression grading score after rebiopsy. Results : 31 patients were included (9 men, 22 women, mean age 52 years), 24 with synchronous PM at diagnosis, 7 with metachronous PM after previous chemotherapy. Mean PCI was 13.8 (min-max 6-34). XELOX was administered in all patients and combined with 56 PIPAC procedures. Complete and partial pathological response was found in 60 % of the 15 patients eligible for tumor response assessment (4 and 5 patients, respectively). Median survival was 13 months. Conclusions : Bidirectional chemotherapy combining XELOX with PIPAC with cisplatin and doxororubicin is well tolerated, can induce objective tumor regression and is associated with a promising survival in PMGC.
- Published
- 2016
- Full Text
- View/download PDF
138. [THE TECHNOLOGY "CELL BLOCK" IN CYTOLOGICAL PRACTICE].
- Author
-
Volchenko NN, Borisova OV, and Baranova IB
- Subjects
- Antibodies, Monoclonal chemistry, Breast Neoplasms pathology, Female, Humans, Image Cytometry, Microtomy, Tissue Embedding instrumentation, Tissue Fixation methods, Breast Neoplasms diagnosis, Exudates and Transudates cytology, Tissue Embedding methods
- Abstract
The article presents summary information concerning application of "cell block" technology in cytological practice. The possibilities of implementation of various modern techniques (immune cytochemnical analysis. FISH, CISH, polymerase chain reaction) with application of "cell block" method are demonstrated. The original results of study of "cell block" technology made with gelatin, AgarCyto and Shadon Cyoblock set are presented. The diagnostic effectiveness of "cell block" technology and common cytological smear and also immune cytochemical analysis on samples of "cell block" technology and fluid cytology were compared. Actually application of "cell block" technology is necessary for ensuring preservation of cell elements for subsequent immune cytochemical and molecular genetic analysis.
- Published
- 2015
139. [Effect of water isotopic composition on Rhodococcus erythropolis biomass production].
- Author
-
Samkov AA, Dzhimak SS, Baryshev MG, Volchenko NN, Khudokormov AA, Samkova SM, and Karaseva ÉV
- Subjects
- Biomass, Deuterium chemistry, Rhodococcus growth & development, Water chemistry
- Abstract
The effect of water isotopic composition on concentration of oil-oxidizing actinobacteria Rhodococcus erythropolis VKM Ac-2017D cellular biomass is observed during cultivation in liquid nutrient media. The value for the effect was determined by experimental conditions, including consecutive use of hydrophilic and hydrophobic nutritious substrates--saccharose and hexadecane. It is shown, that when Rhodococcus erythropolis VKM Ac-2017D cells, cultivated in media with sucrose and 71 and 98 ppm deuterium content in water were inoculated into the similar in mineral and isotopic composition media with hexadecane, a considerable increase in cellular biomass production is observed if compared to a control sample in which water with 150 ppm deuterium concentration was used.
- Published
- 2015
140. [ENDOCYTOSCOPY--NEW TYPE OF ENDOSCOPIC EXAMINATION OF LOWER GASTROINTESTINAL AND RESPIRATORY TRACT].
- Author
-
Pirogov SS, Sokolov VV, Kaprin AD, Sokolov DV, Volchenko NN, Karpova ES, Pavlov PV, Telegina LV, Sukhin DG, Pogorelov NN, Ryabov AB, Khomyakov VM, and Chulikov IA
- Subjects
- Humans, Digestive System Diseases diagnosis, Digestive System Diseases therapy, Endoscopy, Digestive System instrumentation, Endoscopy, Digestive System methods, Respiratory Tract Diseases diagnosis, Respiratory Tract Diseases therapy, Thoracoscopy instrumentation, Thoracoscopy methods
- Abstract
Majority of published data describing endocytoscopic examination of upper gastrointestinal tract mucosa, but in recent publications, it is reported, that endocytoscopy is suitable for small bowel, colon, respiratory tract and even peritoneum "optical biopsy". In number of articles possibilities of celiac sprue diagnostics with endocytoscopy is discussed, but small-bowel endocytoscopy is limited, due to absence of endocytoscopes, compatible with enteroscopes. More widely endocytoscopy is used in colon, mostly in lateral-spreading adenomas diagnostics. Prof. S-E. Kudo developed endocytoscopic classification of colonic mucosa changes, used for differential diagnostics and lesion mapping, describing hyperplasia, adenomas with different grades of intraepithelial neoplasia, non-invasive and invasive cancer. Some authors reported about good possibilities of endocytoscopy in inflammatory bowel disease diagnostics. Most of data, related to respiratory tract endocytoscopic examination, focused on precancerous conditions and early pharyngeal and lung cancer, and the preliminary results are promising, but, unfortunately, for now, endocytoscopy in bronchial tree is limited, due to lack of thin endocytoscopes. According to some article data, it is possible to use endocytoscopy not only in gastrointestinal and respiratory tract, but also in optical confirmation of peritoneal tumor dissemination in gastric and ovarian cancer patients, and--in bladder mucosa examination.
- Published
- 2015
141. [Diagnosis and treatment for Paget's breast cancer: state of the art].
- Author
-
Fetisova EY, Zikiryakhodhaev AD, and Volchenko NN
- Subjects
- Breast Neoplasms epidemiology, Breast Neoplasms pathology, Chemotherapy, Adjuvant, Female, Humans, Mastectomy, Segmental, Paget's Disease, Mammary epidemiology, Paget's Disease, Mammary pathology, Russia epidemiology, Breast Neoplasms diagnosis, Breast Neoplasms therapy, Paget's Disease, Mammary diagnosis, Paget's Disease, Mammary therapy
- Abstract
Breast cancer is the most common cancer in women. According to WHO experts in the world each year there are revealed from 800,000 up to 1 million new cases of breast cancer. In the structure of malignant tumors morbidity among female population, in Russia in 2012 breast cancer ranked the first place (20.7%) and remained the leading malignant pathology in women. Paget's breast cancer is a rare form of breast cancer that occurs in the mouth of the excretory ducts of the nipple, which characterized by lesion of the nipple and large ducts, often with the formation of tumor in the breast. This rare abnormality occurs in 0.5-5% of all cases of breast cancer.
- Published
- 2015
142. [ENDOCYTOSCOPY--NOVEL ENDOSCOPIC DIAGNOSTICS APPROACH: PRINCIPLES AND PROCEDURE].
- Author
-
Pirogov SS, Sokolov VV, Kaprin AD, Volchenko NN, Karpova ES, Pavlov PV, Sukhin DG, Pogorelov NN, Ryabov AB, Khomyakov VM, and Chulikov IA
- Subjects
- Algorithms, Digestive System Diseases therapy, Equipment Design, Humans, Indicators and Reagents, Respiratory Tract Diseases therapy, Staining and Labeling, Digestive System Diseases pathology, Endoscopy, Digestive System instrumentation, Endoscopy, Digestive System methods, Respiratory Tract Diseases pathology, Thoracoscopy instrumentation, Thoracoscopy methods
- Abstract
Endocytoscopy is one of the most novel endoscopic diagnostic procedures, providing optical magnification up to 1150 times of gastrointestinal and respiratory tract mucosa. Such approach allows real-time tissue and cellular structure visualization. Endocytoscopy, along with confocal laser endomicroscopy, can be considered as "optical biopsy" in vivo. Of course, endocytoscopy currently is experimental diagnostic method, all available endocytoscopes are prototypes. According to published data, endocytoscopy can be used in precancerous conditions and early intramucosal cancer diagnostics in esophagus, stomach, colon and bronchial tree. Different types of endocytoscopes are used for examinations: some of them are baby-scopes, with fixed magnification 570-1150 times, introduced into accessory channel of the therapeutic parent-endoscope, others--are integrated type, providing scalable magnification from 80 to 380 times. As for traditional pathology ex vivo, for endocytoscopy mucosal cell nuclei stain is needed. For vital staining during endocytoscopy methylene blue, toluidine blue and crystal violet in different concentrations are more often used. In cases of squamous-cell dysplasia or cancer, it is recommended to use 1% methylene blue solution, whereas in intestinal type metaplasia, dysplastic changes and cancer (Barrett's esophagus, P. Correa precancerous cascade, colon adenomas), 1% toluidine blue is preferred. With endocytoscopy, after vital staining, we can visualize and estimate mucosa tissue and cell characteristics: papillae, crypt and gland shapes and sizes, their integrity (tissue markers); cell nuclei size and shape, polarity and nuclear dye intensity (cell markers).
- Published
- 2015
143. [Rare observation of giant Askin's tumor with localization in anterior mediastinum].
- Author
-
Pikin OV, Volchenko NN, Riabov AB, Glushko VA, Amiraliev AM, Chissov VI, and Kaprin AD
- Subjects
- Antineoplastic Combined Chemotherapy Protocols, Female, Humans, Neoplasm Invasiveness, Neoplasm Staging, Treatment Outcome, Young Adult, Bone Neoplasms drug therapy, Bone Neoplasms pathology, Bone Neoplasms physiopathology, Bone Neoplasms surgery, Mediastinal Neoplasms drug therapy, Mediastinal Neoplasms pathology, Mediastinal Neoplasms physiopathology, Mediastinal Neoplasms surgery, Mediastinum pathology, Mediastinum surgery, Sarcoma, Ewing drug therapy, Sarcoma, Ewing pathology, Sarcoma, Ewing physiopathology, Sarcoma, Ewing surgery, Thoracic Surgical Procedures methods
- Published
- 2014
144. [Early gastric cancer and precancerous conditions diagnostics with confocal laser endomicroscopy].
- Author
-
Pirogov SS, Sokolov VV, Karpova ES, Pavlov PV, Volchenko NN, and Kaprin AD
- Subjects
- Female, Humans, Male, Microscopy, Confocal instrumentation, Microscopy, Confocal methods, Adenoma pathology, Gastric Mucosa pathology, Gastroscopy instrumentation, Gastroscopy methods, Precancerous Conditions pathology, Stomach Neoplasms pathology
- Abstract
Aim: To develop endomicroscopic criteria of early gastric cancer and precancerous conditions, Methods: 157 suspected for early gastric cancer patients were included in our study. In all cases complex endoscopic examination (narrow-band imaging NBI-HD endoscopy, endosonography (EUS) and endoscope-based confocal laser endomicroscopy (CLE) with precise biopsy) was performed. CLE images compared to pathology data., Results: Precise criteria of intestinal metaplasia in CLE was presence of oval gray goblet cells in epithelium. Gastric adenoma with moderate dysplasia appeared on CLE images as glandular structures in mucosa surface layers. The signs of high-grade dysplastic changes in adenoma were appearing of different shape and size cells with lost polarity. Well-differentiated carcinoma featured destruction of some glands and forming dark cell clusters. Revealed criteria of poor-differentiated carcinoma was total disintegration of glandular structures. Overall accuracy of CLE in early gastric cancer and precancerous conditions diagnostics reached 95,6% (P < 0.001). Selected accuracy in different condition was: 100% in intestinal metaplasia identifying, 86.1%--in adenoma with moderate dysplasia, 96.2% in high-grade dysplasia and cancer in situ, and 100%--in poor-differentiated gastric carcinoma types)., Conclusion: As the result of our study we have developed precise endomicroscopic criteria of intestinal metaplasia in stomach, gastric adenoma with moderate and high-grade dysplasia and early gastric cancer--as well-differentiated, as poor-differentiated.
- Published
- 2014
145. [Confocal laser endomicroscopy principles and performing algorithm in gastric mucosa examination].
- Author
-
Pirogov SS, Sokolov VV, Karpova ES, Pavlov PV, Volchenko NN, and Kaprin AD
- Subjects
- Humans, Microscopy, Confocal instrumentation, Microscopy, Confocal methods, Algorithms, Gastric Mucosa pathology, Gastroscopy instrumentation, Gastroscopy methods
- Abstract
Accuracy of endoscopic examination in early gastric cancer and precancerous conditions diagnostics for many years depended only on quality of biopsy. That's why, risk of overlooking gastric focal carcinoma, particularly-- multiple, was relatively high. Last couple of years new endoscopic method--confocal laser endomicroscopy (CLE) was released for commercial use. This approach provides real-time information about morphology of gastric mucosa during endoscopic examination. CLE is a variation of confocal microscopy--morphologic technique, providing examination of thick specimens or live tissue. CLE system is a single-channel fluorescence microscope, used in endoscopy, where confocal probe incorporated into endoscope or mounted into accessory channel. For proper results of CLE intravenous administration of fluorescence agent is needed. In our study in P.A. Herzen Moscow Cancer Research Institute we have used 10% fluorescein sodium, due to acriflavine use is prohibited in Russian Federation. In 157 patients with suspected early gastric cancer mean time of CLE was 24 ± 3.5 min. In all cases descriptive images were acquired. Mean amount of endomicrosocpic images in one patient was as high as 162 ± 8.3.
- Published
- 2014
146. [The application of different types of liquid technologies in cytology].
- Author
-
Volchenko NN, Slavnova EN, and Tugulukova AA
- Subjects
- Female, Humans, Male, Histocytochemistry instrumentation, Histocytochemistry methods
- Abstract
The article discusses the results of comparative study of traditional smears and three different liquid technologies of making ready of cytological preparations (CytoSpin3, E-Prep Processor BD TriPath) using material from 112 patients with pathological processes of such different localizations as exudative liquids (31), soft tissues (22), lymphatic nodes (18), mammal glands (20), saliva glands (7), lungs (9), thyroid gland (5). It is established that under joint application of liquid and traditional cytology the effectiveness of cytological analysis increases up to 3.3%-5% depending on localization of pathologic nidus. The implementation of liquid technologies expands the possibilities of applying immunocitochemistry and molecular genetics to cytological materials.
- Published
- 2013
147. [The role of flow cytofluorometry in cytological diagnostic of non-Hodgkin's lymphomas].
- Author
-
Volchenko NN, Slavnova EN, and Naumova EV
- Subjects
- Humans, Lymphoma, Non-Hodgkin pathology, Sensitivity and Specificity, Flow Cytometry methods, Lymphoma, Non-Hodgkin blood, Lymphoma, Non-Hodgkin diagnosis
- Abstract
The techniques of flow cytofluorometry and immune cytochemistry combined with routine cytological analysis were applied to 81 patients with non-Hodgkin's lymphomas to diagnose the malignant lymphomas and to determine their immune phenotypes. The accuracy of proposed techniques combination to diagnose the malignant lymphoma consists 98% and to determine the immune phenotype - 90%. The presented combination of routine cytological analysis combined with techniques of flow cytofluorometry and immune cytochemistry is the express-technique to diagnose lymphoma and its immune phenotype the day of patient visit to the doctor. This approach significantly increases the role of cytological method in diagnostics of lymphomas. The technique makes it possible to analyze simultaneously huge quantity number of lymph nodes, including deep-seated and not only the superficial lymph nodes.
- Published
- 2012
148. [The fluorescent hybridization in situ as applied in diagnostics of urinary bladder cancer].
- Author
-
Savostikova MV, Volchenko NN, Rusakov IG, Borisova OV, and Golovashchenko MP
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Reproducibility of Results, Urinary Bladder pathology, Urinary Bladder Neoplasms urine, Cytodiagnosis methods, Early Diagnosis, In Situ Hybridization, Fluorescence methods, Urinary Bladder Neoplasms diagnosis, Urinary Bladder Neoplasms genetics
- Abstract
The adaptation of techniques of molecular genetic analysis into clinical practice increased the possibilities of diagnostics of urinary bladder cancer at early stage of disease development. The article discusses the results of cytological and cytogenetic examination of urine cells in patients with diagnostics of urinary bladder cancer. The sampling consisted of 44 cytological and 25 cytogenetic tests. The results of both methods of diagnostics of urinary bladder cancer matched in 12 cases. Besides, in 2 tests the carcinoma of urinary bladder was confirmed only by using molecular genetic technique.
- Published
- 2011
149. [Current possibilities of cytological assay in the study of pleural and peritoneal exudates].
- Author
-
Volchenko NN and Borisova OV
- Subjects
- Cell Separation, Diagnosis, Differential, Early Diagnosis, Female, Flow Cytometry, Fluorescent Antibody Technique methods, Humans, Immunohistochemistry methods, Neoplasms, Glandular and Epithelial secondary, Ovarian Neoplasms secondary, Sensitivity and Specificity, Stomach Neoplasms secondary, Neoplasms, Glandular and Epithelial diagnosis, Neoplasms, Unknown Primary, Ovarian Neoplasms diagnosis, Pleural Effusion, Malignant pathology, Stomach Neoplasms diagnosis
- Abstract
Serous exudates were studied by immunoperoxidase and immunofluorescence immunocytochemical assays and by laser flow cytofluorimetry. The current high-tech techniques detect sparse tumor complexes in the exudates at the early metastatic stages, which are undetectable by the routine cytological assay, and also reduce the hyperdiagnosis of the tumor process. The use of a set of immunocytochemical markers can specify the source of metastatic spread when the primary tumor focus is not found. Fluorescence immunocytochemistry of the exudates has been shown to be highly effective and rapid during emergency intraoperative studies to clarify the extent of the tumor process.
- Published
- 2011
150. [Mistakes in diagnostics and treatment of soft tissue sarcomas].
- Author
-
Tepliakov VV, Karpenko VIu, Sedykh SA, Volchenko NN, Shatalov AM, and Epifanova SV
- Subjects
- Adult, Antineoplastic Agents therapeutic use, Biopsy, Fine-Needle, Delayed Diagnosis prevention & control, Diagnostic Errors prevention & control, Drug Resistance, Neoplasm, Female, Humans, Male, Medication Errors prevention & control, Middle Aged, Neoplasm Staging, Process Assessment, Health Care, Quality Improvement, Rare Diseases diagnosis, Rare Diseases pathology, Rare Diseases therapy, Treatment Failure, Delayed Diagnosis adverse effects, Diagnostic Errors adverse effects, Medication Errors adverse effects, Sarcoma diagnosis, Sarcoma pathology, Sarcoma therapy
- Abstract
120 patients with primary or recurrent soft tissue sarcomas were treated during 1995-2010 years. Analysis of clinical materials allowed singling out most frequent mistakes in diagnostics and treatment that had been made in 52 (43%) patients. High frequency of mistakes caused by rarity of disease, complexity in diagnostics and choice of adequate treatment tactics demands the necessity to concentrate these patients in medical institutions that specialize in treatment of soft tissue sarcomas.
- Published
- 2011
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.